• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulation

by MM360 Staff | May 20, 2025 | Myeloma News

Source: Myeloma : nature.com subject feeds Post Content Read More

Study Reveals Safety and Effectiveness of RSV Vaccine for Older Adults

by MM360 Staff | May 19, 2025 | Myeloma News

Source: Pharmacy Times articles New research highlights the effectiveness and safety of RSV vaccines for older adults, revealing critical insights into vaccination benefits and risks. Read More

First Nationwide Seroprevalence Study of HDV in the US Offers Prevalence of HDV Among HBsAg-Positive Specimens

by MM360 Staff | May 19, 2025 | Myeloma News

Source: Pharmacy Times articles The authors believe the results may serve as a foundation for hepatitis D virus (HDV) testing among hepatitis B virus surface antigen (HBsAg)-positive specimens. Read More

Insights from a Pharmacy Times Peer Exchange: Real-World Outcomes and Supportive Care

by MM360 Staff | May 19, 2025 | Myeloma News

Source: Pharmacy Times articles Pharmacists compare real-world practice data with clinical trial results and discuss supportive care options for patients. Read More

FDA Approved Antihemophilic factor, PEGylated-Aucl For Pediatric Patients With Hemophilia A

by MM360 Staff | May 19, 2025 | Myeloma News

Source: Pharmacy Times articles The approval expands the therapy’s indication to children as young as 7 years of age. Read More

FDA Grants Market Clearance to Diagnostic Blood Test for Alzheimer Disease

by MM360 Staff | May 19, 2025 | Myeloma News

Source: Pharmacy Times articles The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease. Read More
« Older Entries
Next Entries »

Recent Content

  • Automated radiomics model for prediction of therapy response and minimal residual disease from baseline MRI in multiple myeloma
  • Prognostic and clinicopathological value of prognostic nutritional index in patients with multiple myeloma: a meta-analysis
  • Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses
  • Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003)
  • (no title)
  • The risk of second primary malignancies in patients receiving T-cell directed therapies for multiple myeloma: a systematic review
  • (no title)
  • Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes
  • (no title)
  • Efficacy and toxicity of treatment of smoldering multiple myeloma: a systematic review and meta-analysis
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT